治療方案

Dymista®鼻舒達®

2合1鼻敏感噴劑1

5分鐘快速緩解過敏性鼻炎症狀2

Dymista®鼻舒達®（通用名稱：鹽酸氮卓斯汀/丙酸氟替卡松 azelastine hydrochloride/fluticasone propionate）是一種同時含有抗組織胺及類固醇的2合1鼻敏感噴劑，能緩解季節性和常年性過敏性鼻炎症狀。1*

*適用於對單獨使用噴鼻式皮質類固醇或噴鼻式抗組織胺沒有充分反應或不適用的中度至嚴重季節性和常年性過敏性鼻炎患者

為何選擇Dymista®鼻舒達®

鼻舒達®能於5分鐘內，快速緩解過敏性鼻炎的症狀。2

研究亦顯示，鼻舒達®較單獨使用噴鼻式皮質類固醇更有效，且藥效不會因長期使用而下降。3–5

國際指南建議

Azelastine hydrochloride/fluticasone propionate (Dymista®鼻舒達®) 是多個國際及歐洲醫學組織，包括世界過敏組織WAO（World Allergy Organization）、歐洲呼吸學會ERS（European Respiratory Society）和歐洲過敏和氣道疾病研究與教育論壇EUFOREA（European Forum for Research and Education in Allergy and Airway Diseases）等，共同推薦治療中度至嚴重過敏性鼻炎（鼻敏感）的藥物。6

  • 參考資料PM-COR-24-102904 NOV 2024

    1. Dymista® Nasal Spray. Prescribing Information. Version May 2024.
    2. Bousquet J, Meltzer E, Couroux P, et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J Allergy Clin Immunol Pract. 2018;6(5):1726-1732.
    3. Meltzer E, Ratner P, Bachert C, et al. Int Arch Allergy Immunol. 2013;161(4):369-377.
    4. Price D, Bousquet J, Bachert C, et al. A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex. Clin Transl Allergy. 2013;3(Suppl 2):P45.
    5. Price D, Shah S, Bhatia S, et al. A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis. J Investig Allergol Clin Immunol. 2013;23(7):495-503.
    6. Bousquet J, Schunemann H, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.

相關疾病

過敏症

了解更多 ...